Tranexamic acid: why it works on melasma and its limitations

Tranexamic acid originated as a drug. It is a synthetic derivative of lysine, used in medicine to control bleeding because it interferes with the dissolution of blood clots. Its use in serums for dark spots is not a marketing gimmick: it is a clinical discovery that came from observing patients.

Cover image generated with the support of artificial intelligence.

[INDICE:h2]

Why a molecule used for bleeding ended up being used for dark spots

The lead came from a clinical observation: patients being treated for other reasons showed an improvement in facial spots. From there, researchers traced the mechanism, and the mechanism is the truly interesting part.

Tranexamic acid inhibits plasmin activation. In addition to its role in fibrinolysis, plasmin is involved in a chain reaction that starts with UV rays: damage to keratinocytes releases arachidonic acid, which gives rise to prostaglandins that stimulate melanocytes to produce pigment. Reducing plasmin activity means reducing that upstream signal.

There’s also a second component involving the blood vessels: in melasma, it’s not just a matter of overactive melanocytes; there’s also increased vascularization, and this molecule seems to act on that aspect as well.

The difference that makes everything clearer

The brightening agents we’re used to work on production: they interfere with the enzyme that synthesizes melanin. It’s an intervention at the factory.

Tranexamic acid does not do this. It turns down the call ordering production. And that is why it works better precisely where other products disappoint: in melasma, where the spot results from chronic low-grade inflammation, a vascular component, and hormonal stimulation.

The same thing explains its limitation, and it needs to be said: if the signal keeps arriving, the pigment returns. UV rays keep arriving, and so do estrogens. That is why no serum “erases” melasma and why recurrence is not a failure of the product: it is the natural history of the condition.

“It does not shut down the pigment factory. It turns down the voice telling it to work. And if that voice keeps speaking, it needs to keep being turned down.”

The point on which I make no concessions: the oral route

In dermatology, tranexamic acid is also used orally for resistant melasma. It is a medical choice, often outside its approved indications, that is assessed exclusively with a specialist.

The reason is simple and needs to be understood: a molecule that interferes with clot breakdown has real contraindications for people with a personal or family history of thrombosis, during pregnancy, for those taking certain contraceptives, or for anyone with other thrombotic risk factors. This is not a mere formality.

That is why this article includes neither dosages nor regimens: it would not be my role to write them, and reading them in educational content is exactly how someone ends up obtaining on their own something that should have been discussed in a clinic. If your melasma is extensive or resistant, the right path is a dermatologist, not an online order.

What to expect from the version applied to the skin

In cosmetics, you will find it in the INCI as Tranexamic Acid, typically at percentages in the low single digits. These are the reasonable expectations:

• Long timelines. It is assessed at eight to twelve weeks, not three.
• Improved evenness rather than disappearance of the spot.
• Good tolerability, often better than that of other lightening agents, which is its most practical advantage for reactive skin.
• No results without photoprotection. There are no exceptions to this.

It works well in combination: niacinamide acts at another step in the chain, while azelaic acid acts at yet another. Combining different mechanisms is often more effective than increasing the concentration of just one.

How I build a plan for dark spots

The first step is not choosing the active ingredient: it is understanding what kind of dark spot we are dealing with. Melasma, a sun spot, and post-inflammatory hyperpigmentation look similar in the mirror but call for three different strategies. It is the costliest mistake I see: months of using the right product for the wrong problem.

Then the hierarchy is always the same, and first place is non-negotiable: protection every day, even in October, even in the office. For hyperpigmentation, I prefer to use a product that protects while also working on evening out the complexion:

Exfoliation makes sense as an accelerator, not as a solution, and this season it should be done gently: on skin that has just returned from summer, an acid that is too aggressive can trigger precisely the hyperpigmentation we are trying to reduce.

I wrote separately about peels for dark spots, because this is the step where the most damage is done with the best intentions.

And here the channel matters more than the product: distinguishing melasma from post-inflammatory hyperpigmentation by looking at a photo is very difficult, while looking at a person is often a matter of two questions. At the pharmacies and para-pharmacies that distribute LeLang, they know how to ask those two questions, and they also know when the right answer is to send you to a dermatologist instead of selling you a serum.

What I really think

It may be one of the smartest ingredients to have entered the cosmetics field for hyperpigmentation in recent years, and its value lies precisely in what it does not promise.

It does not erase anything. It acts on a signal, doing so elegantly enough to work where more aggressive molecules had failed. But it requires something the market struggles to sell: consistency and protection, for months, without a spectacular before-and-after halfway through.

And it also asks us to distinguish between two things that share the same name. On the skin, it is a cosmetic, and the decision is yours. Taken orally, it is a drug, and the decision is not yours: it belongs to a doctor who knows your medical history. Confusing the two is the main risk of this molecule.